These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 9059333

  • 1. Angiogenesis and metastasis.
    Ellis LM, Fidler IJ.
    Eur J Cancer; 1996 Dec; 32A(14):2451-60. PubMed ID: 9059333
    [No Abstract] [Full Text] [Related]

  • 2. Clinical significance of the determination of angiogenic factors.
    Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T.
    Eur J Cancer; 1996 Dec; 32A(14):2513-9. PubMed ID: 9059341
    [No Abstract] [Full Text] [Related]

  • 3. bFGF and tumor angiogenesis--back in the limelight?
    Rak J, Kerbel RS.
    Nat Med; 1997 Oct; 3(10):1083-4. PubMed ID: 9334715
    [No Abstract] [Full Text] [Related]

  • 4. [Tumor progression and angiogenesis].
    Maru Y.
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1509-19. PubMed ID: 10500543
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor.
    Ferrara N.
    Eur J Cancer; 1996 Dec; 32A(14):2413-22. PubMed ID: 9059329
    [No Abstract] [Full Text] [Related]

  • 6. [Role of angiogenesis in lung cancer and its metastases].
    Yano S, Sone S.
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2131-8. PubMed ID: 10635295
    [Abstract] [Full Text] [Related]

  • 7. Endogenous inhibitors of angiogenesis.
    Ruhrberg C.
    J Cell Sci; 2001 Sep; 114(Pt 18):3215-6. PubMed ID: 11591810
    [No Abstract] [Full Text] [Related]

  • 8. Tumoral vascularity as a prognostic factor in cancer.
    Weidner N, Folkman J.
    Important Adv Oncol; 1996 Sep; ():167-90. PubMed ID: 8791135
    [No Abstract] [Full Text] [Related]

  • 9. Surgical implications of therapeutic angiogenesis.
    Zimmerman MA, Selzman CH, Harken AH.
    Surgery; 1999 Mar; 125(3):243-9. PubMed ID: 10076607
    [No Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor: A Jack-of-all-trades or a nonspecific stress gene?
    Clauss M, Schaper W.
    Circ Res; 2000 Feb 18; 86(3):251-2. PubMed ID: 10679473
    [No Abstract] [Full Text] [Related]

  • 11. The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis.
    Pötgens AJ, Westphal HR, de Waal RM, Ruiter DJ.
    Biol Chem Hoppe Seyler; 1995 Feb 18; 376(2):57-70. PubMed ID: 7540844
    [Abstract] [Full Text] [Related]

  • 12. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
    Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP.
    Prostate; 2001 Dec 01; 49(4):293-305. PubMed ID: 11746276
    [Abstract] [Full Text] [Related]

  • 13. [Tumor angiogenesis].
    Ono M, Kuwano M.
    Seikagaku; 1998 Sep 01; 70(9):1159-70. PubMed ID: 9796411
    [No Abstract] [Full Text] [Related]

  • 14. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?
    Nicosia RF.
    Am J Pathol; 1998 Jul 01; 153(1):11-6. PubMed ID: 9665459
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The diagnostic and prognostic value of tumor angiogenesis.
    Szabo S, Sandor Z.
    Eur J Surg Suppl; 1998 Jul 01; (582):99-103. PubMed ID: 10029373
    [Abstract] [Full Text] [Related]

  • 19. Angiogenesis and angiogenesis inhibition: an overview.
    Folkman J.
    EXS; 1997 Jul 01; 79():1-8. PubMed ID: 9002217
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.